We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Adherence to Clinical Treatment of Glaucoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03338088
Recruitment Status : Active, not recruiting
First Posted : November 9, 2017
Last Update Posted : November 21, 2017
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Evaluation of adherence to clinical treatment of glaucoma in patients of a Reference Ophthalmological Hospital in Goiânia using Morisky Adhesion scale as a validated questionary.

Condition or disease
Glaucoma; Drugs

Study Design

Study Type : Observational [Patient Registry]
Actual Enrollment : 150 participants
Observational Model: Ecologic or Community
Time Perspective: Other
Target Follow-Up Duration: 4 Months
Official Title: Evaluation of Adherence to Clinical Treatment of Glaucoma in Patients of a Reference Ophthalmological Hospital in Goiânia
Actual Study Start Date : September 1, 2017
Primary Completion Date : November 6, 2017
Estimated Study Completion Date : December 30, 2017

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. Evaluation of adherence to clinical treatment of glaucoma in patients of a Reference Ophthalmological Hospital in Goiânia [ Time Frame: 2 months ]
    evaluation of the scale


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   1 Year to 100 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All pacients that have glaucoma diagnosed that respond the questionary
Criteria

Inclusion Criteria: have glaucoma diagnosed -

Exclusion Criteria: not having glaucoma diagnosed

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03338088


Locations
Brazil
Instituto de Olhos de Goiania
Goiânia, Goias, Brazil, 74110120
Instituto de Olhos de Goiania
Goiania, GO, Brazil, 74120-050
Sponsors and Collaborators
Instituto de Olhos de Goiania
Investigators
Study Director: Joao jr Nassaralla, coordinator coordinator
More Information

Responsible Party: Instituto de Olhos de Goiania
ClinicalTrials.gov Identifier: NCT03338088     History of Changes
Other Study ID Numbers: INSTITUTO DE OLHOS-MAYRA 2018
First Posted: November 9, 2017    Key Record Dates
Last Update Posted: November 21, 2017
Last Verified: November 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases